<--- Back to Details
First PageDocument Content
Leukaemia Foundation / Cancer / Management of cancer / Leukemia / Lymphoma / Breast cancer / Acute lymphoblastic leukemia / Children with Leukaemia / Minimal residual disease / Medicine / Oncology / Cancer organizations
Date: 2014-12-08 01:35:41
Leukaemia Foundation
Cancer
Management of cancer
Leukemia
Lymphoma
Breast cancer
Acute lymphoblastic leukemia
Children with Leukaemia
Minimal residual disease
Medicine
Oncology
Cancer organizations

Microsoft Word - WGS[removed]Fact Sheet.docx

Add to Reading List

Source URL: www.worldsgreatestshave.com

Download Document from Source Website

File Size: 424,73 KB

Share Document on Facebook

Similar Documents

MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

DocID: 1vhjk - View Document

Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave

DocID: 1vcJH - View Document

Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version

DocID: 1v6bB - View Document

The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2

DocID: 1uSbg - View Document

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

DocID: 1uJQ2 - View Document